StereoselectiVe Inhibitors of MMP-8
Journal of Medicinal Chemistry, 2006, Vol. 49, No. 3 931
(34) O’Brien, P. M.; Ortwine, D. F.; Pavlovsky, A. G.; Picard, J. A.;
Sliskovic, D. R.; Roth, B. D.; Dyer, R. D.; Johnson, L. L.; Man, C.
F.; Hallak, H. Structure-activity relationships and pharmacokinetic
analysis for a series of potent, systemically available biphenyl-
sulfonamide matrix metalloproteinase inhibitors. J. Med. Chem. 2000,
43, 156-166.
(35) Schudok, M.; Schwab, W.; Zoller, G.; Bartnik, E.; Buttner, F.;
Weithmann, K. U. Sulfonylaminophosphinic and sulfonylamino-
phosphonic acid derivatives, methods for their preparation and use.
Patent US 6,235,727 B1, 2001 and Patent US 6,500,811 B2, 2002.
(36) Parker, M. H.; Ortwine, D. F.; O’Brien, P. M.; Lunney, E. A.; Banotai,
C. A.; Mueller, W. T.; McConnell, P. and Brouillette, C. G.
Stereoselective binding of an enantiomeric pair of stromelysin-1
inhibitors caused by conformational entropy factors. Bioorg Med.
Chem. Lett. 2000, 10, 2427-2430.
(37) Prelog, V.; Helmchen, G. Basic Principles of the CIP-System and
Proposals for a Revision. Angew. Chem., Int. Ed. Engl. 1982, 21,
567-583.
(38) Pavlovsky, A. G.; Williams, M. G.; Ye, Q. Z.; Ortwine, D. F.;
Purchase, C. F., II; White, A. D.; Dhanaraj, V.; Roth, B. D.; Johnson,
L. L.; Hupe, D.; Humblet, C.; Blundell, T. L. X-ray structure of
human stromelysin catalytic domain complexed with nonpeptide
inhibitors: Implications for inhibitor selectivity. Protein Sci. 1999,
8, 1455-1462.
(39) Mikolajczyk, M.; Lyzwa, P.; Drabowicz, J. Asymmetric addition of
dialkyl phosphite and diamido phosphite anions to chiral, enantiopure
sulfinimines: A new, convenient route to enantiomeric R-amino-
phosphonic acids. Tetrahedron Asymmetry 1997, 8, 3991-3994.
(40) Davis, F. A.; Zhang, Y.; Andemichael, Y.; Fang, T.; Fanelli, D. L.;
Zhang, H. Improved synthesis of enantiopure sulfinimines (thiooxime
S-oxides) from p-toluensulfinamide and aldehydes and ketones. J.
Org. Chem. 1999, 64, 1403-1406.
(41) Capozzi, M. A. M.; Cardellicchio, C.; Naso, F.; Spina, G.; Tortorella,
P. Highly stereoselective route to dialkyl sulfoxide based upon the
sequential displacement of oxygen and carbon leaving groups by
Grignard reagents on sulfinyl compounds. J. Org. Chem. 2001, 66,
5933-5936.
(42) Miyuara, N.; Yanagi, T.; Suzuki, A. The palladium-catalyzed cross-
coupling reaction of phenylboronic acid with haloarenes in the
presence of bases. Synth. Commun. 1981, 11, 513-519.
(43) Tronrud, D. E.; Monzingo, A. F.; Matthews, B. W. Crystallographic
structural analysis of phosphoramidates as inhibitors and transition-
state analogs of thermolysin. Eur. J. Biochem. 1986, 157, 261-268.
(44) Holden, H. M.; Tronrud, D. E.; Monzingo, A. F.; Weaver, L. H.;
Matthews, B. W. Slow- and fast-binding inhibitors of thermolysin
display different modes of binding: Crystallographic analysis of
extended phosphonamidate transition-state analogues. Biochemistry
1987, 26, 8542-8553.
(45) Kim, H.; Lipscomb, W. N. Crystal structure of the complex of
carboxypeptidase A with a strongly bound phosphonate in a new
crystalline form: Comparison with structures of other complexes.
Biochemistry 1990, 29, 5546-5555.
(46) Grams, F.; Dive, V.; Yiotakis, A.; Yiallouros, I.; Vassiliou, S.;
Zwilling, R.; Bode, W.; Stocker, W. Structure of astacin with a
transition-state analogue inhibitor. Nat. Struct. Biol. 1996, 3, 671-
675.
(47) Stocker, W.; Grams, F.; Baumann, D.; Reinemer, P.; Gomis-Ruth,
F. X.; McKay, D. B.; Bode, W. The metzincins. Topological and
sequential relations between the astacins, adamalysins, serralysins,
and matrixins (collagenases) define a superfamily of zincpeptidases.
Protein Sci. 1995, 4, 823-840.
(48) Calcagni, A.; Gavuzzo, E.; Lucente, G.; Mazza, F.; Pochetti, G.;
Rossi, D. Structure and conformation of peptides containing the
sulfonamide junction. Int. J. Pept. Protein Res. 1989, 34, 319-324.
(49) Zecchini, G.; Paradisi, M. P.; Torrini, I.; Lucente, G.; Gavuzzo, E.;
Mazza, F.; Pochetti, G. Retrosulfonamido peptide analogues. Syn-
thesis and crystal conformation of Boc-Pro-Leu-Ψ(NH-SO2)-Gly-
NH2. Tetrahedron Lett. 1991, 32, 6779-6782.
(50) Calcagni, A.; Gavuzzo, E.; Mazza, F.; Pinnen, F.; Pochetti, G.; Rossi,
D. Structure and conformation of peptides containing the sulfonamide
junction. IV. Synthesis and crystal conformation of N-benzoyl-L-
phenylalanyl-tauryl-L-leucine methyl ester. Gazz. Chim. ltal. 1992,
122, 17-23.
(51) Calcagni, A.; Rossi, D.; Paglialunga Paradisi, M.; Lucente, G.; Luisi,
G.; Gavuzzo, E.; Mazza, F.; Pochetti, G.; Paci, M. Peptides containing
the sulfonamide junction: Synthesis, structure, and conformation of
Z-Tau-Pro-Phe-NHiPr. Biopolymers 1997, 41, 555-567.
(52) Bode, W.; Reinemer, P.; Huber, R.; Kleine, T.; Schnierer, S.;
Tschesche, H. The X-ray crystal structure of the catalytic domain of
human neutrophil collagenase inhibited by a substrate analogue
reveals the essentials for catalysis and specificity. EMBO J. 1994,
13, 1263-1269.
(53) Reinemer, P.; Grams, F.; Huber, R.; Kleine, T.; Schnierer, S.; Pieper,
M.; Tschesche, H.; Bode, W. Structural implications for the role of
the N terminus in the “superactivation” of collagenases. FEBS Lett.
1994, 338, 227-233.
(54) Grams, F.; Reinemer, P.; Powers, J. C.; Kleine, T.; Pieper, M.;
Tschesche, H.; Huber, R.; Bode, W. X-ray structures of human
neutrophil collagenase complexed with peptide hydroxamate and
peptide thiol inhibitors. Implications for substrate binding and rational
drug design. Eur. J. Biochem. 1995, 228, 830-841.
(55) Stams, T.; Spurlino, J. C.; Smith, D. L.; Wahl, R. C.; Ho, T. F.;
Qoronfleh, M. W.; Banks, T. M.; Rubin, B. Structure of human
neutrophil collagenase reveals large S1′ specificity pocket. Nat. Struct.
Biol. 1994, 1, 119-123.
(56) Grams, F.; Crimmin, M.; Hinnes, L.; Huxley, P.; Pieper, M.;
Tschesche, H.; Bode, W. Structure determination and analysis of
human neutrophil collagenase complexed with a hydroxamate inhibi-
tor. Biochemistry 1995, 34, 14012-14020.
(57) Betz, M.; Huxley, P.; Davies, S. J.; Mushtaq, Y.; Pieper, M.;
Tschesche, H.; Bode, W.; Gomis-Ru¨th, F. X. 1.8-Å crystal structure
of the catalytic domain of human neutrophil collagenase (matrix
metalloproteinase-8) complexed with a peptidomimetic hydroxamate
primed-side inhibitor with a distinct selectivity profile. Eur. J.
Biochem. 1997, 247, 356-363.
(58) Brandstetter, H.; Engh, R. A.; Graf Von Roedern, E.; Moroder, L.;
Huber, R.; Bode, W.; Grams, F. Structure of malonic acid-based
inhibitors bound to human neutrophil collagenase. A new binding
mode explains apparently anomalous data. Protein Sci. 1998, 7,
1303-1309.
(59) The geometry of an R-R-sulfonylaminophosphonate is superimposable
with that of the S-carboxylate analogue, owing to the inversion of
the priority order of the substituents at CR.37
(60) Knight, C. G.; Willenbrock, F.; Murphy, G. A novel coumarin-
labelled peptide for sensitive continuous assays of the matrix
metalloproteinases. FEBS Lett. 1992, 296, 263-266.
(61) Schnierer, S.; Kleine, T.; Gote, T.; Hillemann, A.; Kna¨uper, V.;
Tschesche, H. The recombinant catalytic domain of human neutrophil
collagenase lacks type I collagen substrate specificity. Biochem.
Biophys. Res. Commun. 1993, 191, 319-326.
(62) Otwinowski, Z.; Minor, W. Processing of X-ray diffraction data
collection in oscillation mode. Methods Enzymol. 1997, 276, 307-
326.
(63) Brunger, A. T.; Adams, P. D.; Clore, G. M.; DeLano, W. L.; Gros,
P.; Grosse-Kunstleve, R. W.; Jiang, J. S.; Kuszewski, J.; Nilges, M.;
Pannu, N. S.; Read, R. J.; Rice, L. M.; Simonson, T.; Warren, G. L.
Crystallography and NMR system: A new software suite for
macromolecular structure determination. Acta Crystallogr. 1998, D54,
905-921.
JM050787+